⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LXRX News
Lexicon Pharmaceuticals, Inc.
Form 8-K
sec.gov
LXRX
Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
globenewswire.com
LXRX
Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
globenewswire.com
LXRX
Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo
globenewswire.com
LXRX
Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851
globenewswire.com
LXRX
Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes
globenewswire.com
LXRX
Form 8-K
sec.gov
LXRX
Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates
globenewswire.com
LXRX
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
prnewswire.com
MLYS
PROK
IRON
REGN
AMGN
MAZE
LLY
JNJ
LXRX
Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
globenewswire.com
LXRX